WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models is a research paper published in Neuro-Oncology Advances (2023). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors
Grant: U54CA210180
Mayo Clinic
Grant: P41-EB028741
National Institutes of Health
Grant: T32EB025823
NIBIB NIH HHS
Grant: P41 EB028741
European Commission
Grant: 713679
Martí i Franquès COFUND
National Institutes of Health
Grant: 1P41EB028741-01A1
Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
National Institutes of Health
Grant: 5T32EB025823-05
Training in Image Guidance, Precision Diagnosis and Therapy
National Institutes of Health
Grant: 1U54CA210180-01
MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors
Massachusetts Life Sciences Center
FWCI
0.82
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals